Compile Data Set for Download or QSAR
Report error Found 376 Enz. Inhib. hit(s) with Target = 'GTPase KRas [1-169,G12D]'
TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713028BDBM713028(US20250019385, Example II-12)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712985BDBM712985(US20250019385, Example I-31)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713027BDBM713027(US20250019385, Example II-11)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713026BDBM713026(US20250019385, Example II-10)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712983BDBM712983(US20250019385, Example I-29)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713025BDBM713025(US20250019385, Example II-9b)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713032BDBM713032(US20250019385, Example II-16)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712955BDBM712955(US20250019385, Example I-3)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713033BDBM713033(US20250019385, Example II-17)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713031BDBM713031(US20250019385, Example II-15)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713029BDBM713029(US20250019385, Example II-13)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712952BDBM712952(US20250019385, Example I-1)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713030BDBM713030(US20250019385, Example II-14)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713019BDBM713019(US20250019385, Example II-5)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712976BDBM712976(US20250019385, Example I-23)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713016BDBM713016(US20250019385, Example II-4)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712974BDBM712974(US20250019385, Example I-21)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713013BDBM713013(US20250019385, Example II-2)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713023BDBM713023(US20250019385, Example II-8)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712980BDBM712980(US20250019385, Example I-26)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713020BDBM713020(US20250019385, Example II-6)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713005BDBM713005(US20250019385, Example I-52)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713000BDBM713000(US20250019385, Example I-46)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712966BDBM712966(US20250019385, Example I-14)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713001BDBM713001(US20250019385, Example I-47)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712999BDBM712999(US20250019385, Example I-45)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713011BDBM713011(US20250019385, Example I-58)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712973BDBM712973(US20250019385, Example I-20)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713012BDBM713012(US20250019385, Example II-1)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713009BDBM713009(US20250019385, Example I-56)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713010BDBM713010(US20250019385, Example I-57)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 472647BDBM472647(US10829487, Example I-130)
Affinity DataIC50: 1nMAssay Description:Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713008BDBM713008(US20250019385, Example I-55)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713006BDBM713006(US20250019385, Example I-53)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 472582BDBM472582(US10829487, Example I-61)
Affinity DataIC50: 1nMAssay Description:Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713007BDBM713007(US20250019385, Example I-54)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712960BDBM712960(US20250019385, Example I-8)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712993BDBM712993(US20250019385, Example I-39)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713035BDBM713035(US20250019385, Example II-20)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712964BDBM712964(US20250019385, Example I-12)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712998BDBM712998(US20250019385, Example I-44)
Affinity DataIC50: 1nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712986BDBM712986(US20250019385, Example I-32)
Affinity DataIC50: 2nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712984BDBM712984(US20250019385, Example I-30)
Affinity DataIC50: 2nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 713034BDBM713034(US20250019385, Example II-18)
Affinity DataIC50: 2nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712990BDBM712990(US20250019385, Example I-36)
Affinity DataIC50: 2nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 712954BDBM712954(US20250019385, Example I-2)
Affinity DataIC50: 2nMAssay Description:This assay can be used to examine the potency with which compounds according to the invention binding to (mutated) KRAS inhibit the protein-protein i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/26/2025
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 472579BDBM472579(US10829487, Example I-58)
Affinity DataIC50: 2nMAssay Description:Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 472641BDBM472641(US10829487, Example I-124)
Affinity DataIC50: 2nMAssay Description:Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 472578BDBM472578(US10829487, Example I-57)
Affinity DataIC50: 2nMAssay Description:Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 472642BDBM472642(US10829487, Example I-125)
Affinity DataIC50: 2nMAssay Description:Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/28/2021
Entry Details
US Patent

Displayed 1 to 50 (of 376 total ) | Next | Last >>
Jump to: